We audited the accuracy of the Systemic Anti-Cancer Therapy dataset as a resource for rapid analysis of outcomes for patients, in this example, receiving Cancer Drug Fund funded monoclonal antibodies to treat metastatic colorectal cancer. We concluded that the Systemic Anti-Cancer Therapy dataset is a potentially valuable resource for rapidly determining survival outcome for patients treated with chemotherapy.
|Publication status||Published - Jul 2017|
Bibliographical notePublisher Copyright:
- Cancer Drug Fund
- Systemic Anti-Cancer Therapy dataset